Effect of factor XIII VAL34LEU polymorphism on thrombolytic therapy in premature myocardial infarction

Thromb Haemost. 2002 Aug;88(2):354-5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Age of Onset
  • Factor XIII / genetics
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / genetics*
  • Pharmacogenetics
  • Polymorphism, Single Nucleotide
  • Retrospective Studies
  • Thrombolytic Therapy

Substances

  • Factor XIII